-
Product Insights
NewLikelihood of Approval Analysis for Thyroid Gland Disorders
Overview How likely is it that the drugs in Thyroid Gland Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Thyroid Gland Disorders Overview Thyroid gland disorders are conditions that affect...
-
Product Insights
NewLikelihood of Approval Analysis for Filoviridae Infections
Overview How likely is it that the drugs in Filoviridae Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Filoviridae Infections Overview Filovirideae infections are caused by viruses in the family...
-
Product Insights
NewLikelihood of Approval Analysis for Flaviviridae Infections
Overview How likely is it that the drugs in Flaviviridae Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Flaviviridae Infections Overview Fiavivirideae infections are caused by a family of enveloped...
-
Product Insights
NewLikelihood of Approval Analysis for Urinary Tract Infections
Overview How likely is it that the drugs in Urinary Tract Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Urinary Tract Infections Overview A urinary tract infection (UTI) is a...
-
Product Insights
NewLikelihood of Approval Analysis for Arteriosclerosis
Overview How likely is it that the drugs in Arteriosclerosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Arteriosclerosis Overview Arteriosclerosis refers to the thickening and hardening of arteries due to...
-
Product Insights
NewLikelihood of Approval Analysis for Gastroesophageal (GE) Junction Carcinomas
Overview How likely is it that the drugs in Gastroesophageal (GE) Junction Carcinomas will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Gastroesophageal (GE) Junction Carcinomas Overview Gastroesophageal (GE) junction carcinomas are...
-
Product Insights
NewLikelihood of Approval Analysis for Enterovirus Infections
Overview How likely is it that the drugs in Enterovirus Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Enterovirus Infections Overview Enteroviruses are a group of viruses that cause various...
-
Product Insights
NewLikelihood of Approval Analysis for Hyperlipidemia
Overview How likely is it that the drugs in Hyperlipidemia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hyperlipidemia Overview Hyperlipidemia is a medical condition characterized by elevated levels of lipids...
-
Product Insights
NewLikelihood of Approval Analysis for Burns
Overview How likely is it that the drugs in Burns will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Burns Overview Burns result from tissue damage caused by heat, chemicals, electricity, or...
-
Product Insights
NewLikelihood of Approval Analysis for Systolic Heart Failure
Overview How likely is it that the drugs in Systolic Heart Failure will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Systolic Heart Failure Overview Systolic heart failure is a cardiovascular disorder...